A Prospective Multicenter Observational Study for Dacogen Long-Term Treatment in Patients With Myelodysplastic Syndrome.
Phase of Trial: Phase IV
Latest Information Update: 25 Jul 2014
At a glance
- Drugs Decitabine (Primary)
- Indications Myelodysplastic syndromes
- Focus Therapeutic Use
- Sponsors Janssen
- 16 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Feb 2014 Planned End Date changed from 1 Dec 2015 to 1 Apr 2014 as reported by ClinicalTrials.gov.
- 29 Jun 2012 Actual patients number changed from 126 to 145 as reported by ClinicalTrials.gov.